View Moderna Vaccine Timeline Images. Moderna said its experimental coronavirus vaccine was nearly 95 percent effective in a pivotal study, adding to hopes that an inoculation for the deadly virus could be available soon. Moderna, like pfizer, says their vaccine was generally well tolerated during the trials.
Moderna, the massachusetts biotechnology company behind a leading effort to create a coronavirus vaccine, announced promising early results monday from its first human safety tests. Moderna vaccine found highly effective at preventing covid. It was part of the federal government's operation warp speed initiative and the company.
However, this is still early data and key questions remain unanswered.
Moderna reveals new vaccine that is 94.5% effective, cheaper and easier to distribute than pfizer's moderna becomes the second firm to announce early results from a clinical trial, suggesting 94.5. Moderna developed its vaccine in conjunction with the national institute of allergy and infectious diseases. However the moderna vaccine is more expensive and there are fewer doses available in the next this announcement from moderna is a further encouragement that vaccines will be found to not. It was part of the federal government's operation warp speed initiative and the company.